CDKN2B and cancer: Functional investigations suggested that CDKN2B‐AS1 promoted carcinogenesis by modulating the expression of tumour suppressor genes, CDKN2A/CDKN2B, in cis,22, 23 indicating a therapeutic potential for cancers.